GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Optica Publishing Group ; 2011
    In:  Optics Express Vol. 19, No. 10 ( 2011-05-09), p. 9699-
    In: Optics Express, Optica Publishing Group, Vol. 19, No. 10 ( 2011-05-09), p. 9699-
    Type of Medium: Online Resource
    ISSN: 1094-4087
    Language: English
    Publisher: Optica Publishing Group
    Publication Date: 2011
    detail.hit.zdb_id: 1491859-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Blood, American Society of Hematology, Vol. 128, No. 22 ( 2016-12-02), p. 954-954
    Abstract: Calreticulin (CALR) exon 9 mutations were reported in about two-thirds of JAK2 or MPL mutation negative ET and PMF patients. The mutations cause frameshifts that result in proteins with novel C-terminus.Retrovirus-mediated gene transfer into cell lines and mouse bone marrow (BM) cells is a common technique, but the expression level is very high compared to the physiological expression.We investigated the effects of physiological expression of mutant CALR using CRISPR/Cas9 gene editing techniques for cell lines, and as for the mouse model, we generated a transgenic mice (TG) expressing human CALR del52 mutant. We used two human cell lines expressing MPL: human acute megakaryoblastic leukemia cell line CMK11-5 which expressed endogenous MPL, and F-36P-MPL cell line which was generated by introducing MPL to GM-CSF-dependent erythroleukemia cell line F-36P. Plasmids coexpressing hCas9 and single-guide RNA were prepared by ligating oligonucleotides (5'-CACCGACAAGAAACGCAAAGAGGAGG-3', 5'-AAACCCTCCTCTTTGCGTTTCTTGTC-3') for the target sequence of human CALR exon 9 into pX330. The plasmids were introduced with a electroporator to each of the cell lines. After limiting dilution cloning, we identified cell lines which have indel mutation at the target site. We produced two types of CMK11-5 subline knocked in a CALR mutation, namely CALR del25 CMK cells and CALR del25/del17 CMK cells, respectively. The former lacks 25 bases in one CALR allele, causing a frameshift that results in a protein resembling human CALR mutant, while the latter lacks an additional 17 bases in another allele in CALR exon 9 and induces a frameshift that causes a deletion in CALR exon 9. Both kinds of CALR mutant CMK11-5 cells showed increased cell proliferation compared to WT cells. We also produced one type of F-36P-MPL subline, CALR del1/ins1 F-36P-MPL cells which had 1 base deletion in one CALR allele resembling human mutation and 1 base insertion in another allele. Though the growth of this subline in the presence of GM-CSF was comparable to WT cells, it showed GM-CSF independent autonomous cell growth. We generated TG mice expressing human CALR del52 mutant driven by the murine H2Kb promoter. We compared the expression level of human CALR mRNA in TG BM cells with the expression of endogenous WT CALR in human cell lines (CMK11-5, F-36P-MPL, CHRF288) using Rn18s as an endogenous control. The expression of human CALR in TG BM was approximately 0.6 times that of endogenous WT CALR in human cell lines, and the physiological expression level was obtained. They exhibited thrombocytosis, with platelet (PLT) counts as high as 2,000 x 109/L. Leukocyte number and the proportion of granulocytes and T and B lymphocytes, were comparable to WT mice. CALR mutation had no impact on Hb level or spleen weight. There was a striking difference in the number of megakaryocytes (Mgks), which was 2-fold higher in BM from TG mice than in WT mice. The TG Mgks were also more mature, with larger diameter, and contained higher number of alpha-granules compared to WT cells. In one year of observation, there is no fibrosis in BM. These observations showed that TG developed human ET-like disease. The survival of TG mice was comparable to that of WT mice. The disease phenotype was transplantable into WT recipient mice. To characterize in detail the impact of MPNs induced by the CALR del52 mutant, we evaluated the frequencies of HSCs and progenitors in BM. The frequency of both LT-HSC and ST-HSC in BM was higher inTG mice compared to WT mice. The frequencies of progenitors (CMP, MEP, and MKP) were also greater in BM from TG mice than from WT mice. However, BM cells did not have enhanced replating capacity. We next examined whether or not ruxolitinib (RUX) treatment ameliorated thrombocytosis in TG mice. Either 90 mg/kg bid of RUX or vehicle was administrated to TG mice for 4 weeks.TG mice treated with vehicle showed a mean 16% increase in PLT count during the treatment period, probably due to the disease progression. RUX treatment attenuated the increase in the number of PLTs in TG mice by a mean of 22%, but the overall count was still higher than that in WT mice. BM sections showed that RUX reduced the Mgks number in TG. In summary, physiological expression of CALR mutant increases cell growth and cytokine independency in human cell lines expressing MPL, and develops ET in mice. RUX therapy attenuated the increased numbers of peripheral blood PLTs and BM Mgks, and ameliorated CALR mutation-induced ET. Disclosures No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2016
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Electrochemistry, The Electrochemical Society of Japan, Vol. 86, No. 6 ( 2018-11-5), p. 339-344
    Type of Medium: Online Resource
    ISSN: 1344-3542 , 2186-2451
    Language: English
    Publisher: The Electrochemical Society of Japan
    Publication Date: 2018
    detail.hit.zdb_id: 2938378-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Journal of Clinical and Molecular Medicine, Open Access Text Pvt, Ltd., Vol. 4, No. 1 ( 2020)
    Type of Medium: Online Resource
    ISSN: 2516-5593
    Language: Unknown
    Publisher: Open Access Text Pvt, Ltd.
    Publication Date: 2020
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: BMC Pulmonary Medicine, Springer Science and Business Media LLC, Vol. 21, No. 1 ( 2021-12)
    Abstract: In chronic obstructive pulmonary disease (COPD) patients, combination treatment with long-acting muscarinic antagonist (LAMA) and long-acting β2 agonist (LABA) increases forced expiratory volume in one second and reduces symptoms compared to monotherapy. In Japan, three different once-daily fixed-dose combinations (FDCs) have been prescribed since 2015, although a direct comparison of these FDCs has never been performed. The objective of the present study was to compare the effectiveness, preference, and safety of three LAMA/LABA FDCs—glycopyrronium/indacaterol (Gly/Ind), umeclidinium/vilanterol (Ume/Vil), and tiotropium/olodaterol (Tio/Olo)—in patients with COPD. Methods We enrolled 75 COPD outpatients (male:female ratio, 69:6; 77.4 ± 6.9 years). A prospective, randomized, crossover study was conducted on three groups using three FDCs: Gly/Ind; Ume/Vil; and Tio/Olo. Each medication was administered for 4 weeks before crossover (total 12 weeks). After each FDC administration, a respiratory function test and questionnaire survey were conducted. A comparative questionnaire survey of all three LAMA/LABA FDCs was conducted after 12 weeks (following administration of final FDC). Results No significant differences in COPD Assessment Test or modified Medical Research Council dyspnea questionnaire were reported in the surveys completed after each FDC administration; no significant differences in spirometric items were observed. In the final comparative questionnaire survey, patients reported better actual feeling of being able to inhale following Gly/Ind administration compared with Tio/Olo, although no significant differences in adverse events or other evaluations were reported. Conclusions The three LAMA/LABA FDCs administered to COPD patients show similar effects and safety, although some minor individual preference was reported. Trial registration This study retrospectively registered with the University Hospital Medical Information Network Clinical Trials Registry (number UMIN000041342, registered on August 6, 2020).
    Type of Medium: Online Resource
    ISSN: 1471-2466
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2021
    detail.hit.zdb_id: 2059871-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cell Structure and Function, Japan Society for Cell Biology, Vol. 40, No. 1 ( 2015), p. 13-30
    Type of Medium: Online Resource
    ISSN: 0386-7196 , 1347-3700
    Language: English
    Publisher: Japan Society for Cell Biology
    Publication Date: 2015
    detail.hit.zdb_id: 2038274-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2017
    In:  Electrocatalysis Vol. 8, No. 2 ( 2017-3), p. 164-169
    In: Electrocatalysis, Springer Science and Business Media LLC, Vol. 8, No. 2 ( 2017-3), p. 164-169
    Type of Medium: Online Resource
    ISSN: 1868-2529 , 1868-5994
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2017
    detail.hit.zdb_id: 2543106-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Atomic Energy Society of Japan ; 2012
    In:  Journal of Nuclear Fuel Cycle and Environment Vol. 19, No. 2 ( 2012), p. 23-38
    In: Journal of Nuclear Fuel Cycle and Environment, Atomic Energy Society of Japan, Vol. 19, No. 2 ( 2012), p. 23-38
    Type of Medium: Online Resource
    ISSN: 1884-7579 , 2186-7135
    Uniform Title: TRU廃棄物の地層処分における高アルカリ性地下水の拡がりに関する地球化学-物質移行解析による検討
    Language: English , Japanese
    Publisher: Atomic Energy Society of Japan
    Publication Date: 2012
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Medicines, MDPI AG, Vol. 8, No. 2 ( 2021-02-01), p. 9-
    Abstract: Background: Genetic hypomyelinating diseases are a heterogeneous group of disorders involving the white matter. One infantile hypomyelinating leukoencephalopathy is associated with the homozygous variant (Cys4-to-Ser (C4S)) of the c11orf73 gene. Methods: We observed that in mouse oligodendroglial FBD-102b cells, the C4S mutant proteins but not the wild type ones of C11orf73 are microscopically localized in the lysosome. And, they downregulate lysosome-related signaling in an immunoblotting technique. Results: The C4S mutant proteins specifically interact with Filamin A, which is known to anchor transmembrane proteins to the actin cytoskeleton; the C4S mutant proteins and Filamin A are also observed in the lysosome fraction. While parental FBD-102b cells and cells harboring the wild type constructs exhibit morphological differentiation, cells harboring C4S mutant constructs do not. It may be that morphological differentiation is inhibited because expression of these C4S mutant proteins leads to defects in the actin cytoskeletal network involving Filamin A. Conclusions: The findings that leukoencephalopathy-associated C11ORF73 mutant proteins specifically interact with Filamin A, are localized in the lysosome, and inhibit morphological differentiation shed light on the molecular and cellular pathological mechanisms that underlie infantile hypomyelinating leukoencephalopathy.
    Type of Medium: Online Resource
    ISSN: 2305-6320
    Language: English
    Publisher: MDPI AG
    Publication Date: 2021
    detail.hit.zdb_id: 2777965-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: ECS Meeting Abstracts, The Electrochemical Society, Vol. MA2015-02, No. 37 ( 2015-07-07), p. 1522-1522
    Abstract: Introduction  Potential of renewable energy is uneven distribution with fluctuation; therefore, to increase renewable energies, energy carrier technology is needed for storage and transportation. Hydrogen can be produced with various energies, but its volumetric energy density is too low to storage and transport. Toluene-methylcyclohexane organic chemical hydride system is one of promising technologies as hydrogen storage and transportation by invention of the dehydrogenation catalyst (1). Electrohydrogenation of toluene with water splitting has higher theoretical energy conversion efficiency compare to a series process of water electrolysis and hydrogenation. Direct and indirect electrohydrogenation processes had been proposed (2, 3). However, further challenge is needed to improve efficiency, durability, and increasing of the scale. We focused on a membrane electrolysis as a direct process with water splitting. Cathode side is a cathode membrane assembly, which is applied PEFC technology with precious metal loaded carbon electrocatalyst. Anode is a dimensionally stable electrode for oxygen evolution reaction in acidic electrolyte using industrial electrolysis technology. In our previous study, cell voltage of electrohydrogenation of toluene was almost as same as water electrolysis, but internal resistance of the electrolyzer was not small enough and conversion was very low (4).  In this study, the membrane of anode side was hydrophilized to release oxygen from anode to reduce internal resistance, and characteristics of low concentration of toluene has been evaluated to reach high conversion to methylcyclohexane. Experimental A cathode was a carbon paper (35BC, SGL) coated 0.5 mgcm -2 of PtRu (TEC61E54, TKK) with Nafion dispersion. The cathode was pressed on a perfluoroethylene sulfuric acid (PFSA) membrane (Nafion ® 212CS, DuPont) for a cathode membrane assembly. The membrane of the cathode side was hydrophilized by ZrO 2 power coating or mechanically roughing. A non-treated membrane was also used for comparison. A DSE ® anode with IrO 2 based electrocatalyst is used for oxygen evolution. Toluene/methylcyclohexane mixture and 1M (=moldm -3 ) of H 2 SO 4 were supplied to the cathode and anode for hydrogenation of toluene, respectively. The toluene concentration was in the range from 1 to 100 %. Cell voltage was determined with 4 mVs -1 of voltage sweep from 0.6 for toluene hydrogenation. Current efficiency was determined with constant cell voltage electrolysis with the volume measurement of gas evolution from cathode during the electrolysis. Internal resistance (iR) was determined with higher frequency intercept of AC impedance method in the cell voltage range from 1.0 to 2.5 V. Results and discussion  Figure 1 shows the internal resistance and cell voltage as a function of current density for 100 % TL fed with various membrane treatments of anode side. The output of H 2 SO 4 pulsed especially in high current density region, and current fluctuated above 2.2 V of the cell voltage with hydrogen evolution from cathode. This behavior would be affected by oxygen release between the membrane and the anode. The cell voltage and resistance of the hydrophilized membranes was smaller than those of non-treated membrane. At this moment, the output of H 2 SO 4 and oxygen mixture was smooth, and there was no gas evolution reaction from cathode. Figure 2 shows the cell voltage (a) and current efficiency of hydrogenation as a function of current density for 1 to 100 % of TL-MCH fed with the rough surface membrane cell. The side reaction is only hydrogen evolution for this system. Error bars were current variation during constant cell voltage electrolysis for current and current efficiency measurements. The lines show the polarization curves with 4 mVs -1 of cell voltage sweep. For 100 and 50 % of TL fed, the current efficiency of electrohydrogenation was above 97 % up to the limit of current source of 0.44 Acm -2 . At this moment, electrolysis was stable, and the cell voltage was around 2.0 V at 0.4 Acm -2 . Below 10 % of TL fed, simultaneously hydrogen evolution proceeded at higher current density region with current variation. Therefore, this process should be feasible, and improvement of mass transfer in the cathode catalyst layer is important issue for real application. Acknowledgment This work was supported by Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), “energy carrier” (Funding agency: JST). We applicate the person concerned them. References 1) Y. Okada, E. Sasaki, E. Watanabe, S. Hyodo, H. Nishijima, J. Hydrogen Energy, 2006, 31, 1348. 2) T. Hirashige, T. Ishikawa, M. Sugimasa, WO 2011/122155 Al (PCT/JP2011/053478) 2011. 3) C. Iwakura, Y. Yoshida, S. Ogata, H. Inoue, J. Mater. Res., 2011, 13, 821. 4) S. Mitsushima, Y. Takakuwa, Y. Kohno, K. Matsuzawa, A. Kato, Y. Nishiki, Abstract of 226 th meeting of the ECS, #619 (2014). Figure 1
    Type of Medium: Online Resource
    ISSN: 2151-2043
    Language: Unknown
    Publisher: The Electrochemical Society
    Publication Date: 2015
    detail.hit.zdb_id: 2438749-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...